论文部分内容阅读
目的探讨三拗片联合盐酸氨溴索注射液治疗慢性支气管炎的临床疗效。方法选取2012年1月—2014年1月静宁县人民医院收治的慢性支气管炎患者100例,采用随机数字表法将其分为观察组与对照组,各50例。观察组患者给予盐酸氨溴索注射液联合三拗片治疗,对照组患者给予盐酸氨溴索注射液治疗,比较两组患者临床疗效、症状缓解时间(包括咳嗽、咳痰、气喘、肺部啰音)及不良反应发生情况。结果观察组总有效率为96.0%(48/50);高于对照组的78.0%(39/50),差异有统计学意义(P<0.05);两组患者治疗后症状(包括咳嗽、咳痰、肺部啰音及气喘)缓解时间短于对照组,差异有统计学意义(P<0.05);观察组不良反应发生率为4.0%(2/50),对照组为8.0%(4/50),组间比较,差异无统计学意义(P>0.05)。结论三拗片联合盐酸氨溴索注射液治疗慢性支气管炎的疗效显著,可有效改善患者临床症状,且不良反应少。
Objective To investigate the clinical efficacy of Sanwei tablets combined with ambroxol hydrochloride injection in the treatment of chronic bronchitis. Methods One hundred patients with chronic bronchitis admitted from January 2012 to January 2014 in Jingning People’s Hospital were enrolled and divided into observation group and control group with 50 cases in each group by random number table. Patients in the observation group were treated with Ambroxol Hydrochloride Injection in combination with Sanwei Tablet, while patients in the control group were treated with Ambroxol Hydrochloride Injection. The clinical efficacy, symptom relief time (including cough, sputum, asthma and lungs) were compared between the two groups Tone) and adverse reactions occurred. Results The total effective rate was 96.0% (48/50) in observation group and 78.0% (39/50) in control group, with significant difference (P <0.05). After treatment, the symptoms of both groups (including cough and cough Sputum, pulmonary rales and asthma) were shorter than those in the control group (P <0.05). The incidence of adverse reactions in the observation group was 4.0% (2/50) and in the control group was 8.0% (4 / 50). There was no significant difference between groups (P> 0.05). Conclusion Sanwei tablet combined with ambroxol hydrochloride injection has significant curative effect on chronic bronchitis, which can effectively improve the clinical symptoms of patients with less adverse reactions.